498 related articles for article (PubMed ID: 21916970)
1. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
5. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
7. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
[TBL] [Abstract][Full Text] [Related]
9. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
[TBL] [Abstract][Full Text] [Related]
10. Microvascular Complications and Prevalence of Nocturia in Japanese Patients With Type 2 Diabetes Mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Urology; 2016 Jul; 93():147-51. PubMed ID: 26995392
[TBL] [Abstract][Full Text] [Related]
11. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.
Lutgers HL; Graaff R; Links TP; Ubink-Veltmaat LJ; Bilo HJ; Gans RO; Smit AJ
Diabetes Care; 2006 Dec; 29(12):2654-9. PubMed ID: 17130200
[TBL] [Abstract][Full Text] [Related]
12. Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
van Eupen MG; Schram MT; van Sloten TT; Scheijen J; Sep SJ; van der Kallen CJ; Dagnelie PC; Koster A; Schaper N; Henry RM; Kroon AA; Smit AJ; Stehouwer CD; Schalkwijk CG
Hypertension; 2016 Oct; 68(4):956-63. PubMed ID: 27550921
[TBL] [Abstract][Full Text] [Related]
13. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
[TBL] [Abstract][Full Text] [Related]
15. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
Yue X; Hu H; Koetsier M; Graaff R; Han C
Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
[TBL] [Abstract][Full Text] [Related]
17. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.
Lutgers HL; Gerrits EG; Graaff R; Links TP; Sluiter WJ; Gans RO; Bilo HJ; Smit AJ
Diabetologia; 2009 May; 52(5):789-97. PubMed ID: 19274450
[TBL] [Abstract][Full Text] [Related]
18. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
